Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human

S J Warner1, G B Friedman, P Libby

  • 1Department of Medicine, New England Medical Center, Boston, Massachusetts.

Insights

Interferon-gamma (IFN-γ) inhibits vascular smooth muscle cell (SMC) proliferation, a key factor in atherosclerosis development. This finding suggests IFN-γ, produced by T cells in plaques, may influence the balance of growth factors in human atherogenesis.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Vascular smooth muscle cell (SMC) proliferation is crucial in human atherosclerotic plaque formation.
  • Macrophages and T lymphocytes within lesions secrete SMC mitogens and immune signaling molecules.
  • SMC in atherosclerotic lesions often express class II major histocompatibility antigens, indicating local T cell activation and interferon-gamma (IFN-γ) production.

Purpose of the Study:

  • To investigate the direct effect of IFN-γ on the proliferation of cultured human vascular SMC.
  • To determine if IFN-γ influences SMC response to known mitogens like IL-1 and platelet-derived growth factor (PDGF).
  • To explore the potential role of IFN-γ in regulating SMC accumulation during atherogenesis.

Main Methods:

  • Cultured human vascular SMC were treated with IFN-γ (1,000 U/ml) and stimulated with IL-1 or PDGF.
  • [3H]thymidine incorporation into DNA was measured to assess proliferation.
  • Longer-term experiments monitored net DNA accumulation, and kinetic studies analyzed c-fos RNA expression.

Main Results:

  • IFN-γ significantly reduced [3H]thymidine incorporation in SMC stimulated by IL-1 or PDGF.
  • IFN-γ prevented net DNA accumulation in PDGF-stimulated SMC over 4-16 days.
  • IFN-γ delayed the peak expression of c-fos RNA in IL-1-treated SMC, indicating an impact on early growth signaling.

Conclusions:

  • IFN-γ exhibits a cytostatic effect on human vascular SMC proliferation.
  • This anti-proliferative action of IFN-γ may play a role in modulating SMC accumulation within atherosclerotic plaques.
  • The local production of IFN-γ by T cells in plaques could influence the balance of growth factors in human atherogenesis.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.0K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73